01 2Allergan, Inc.
02 2LYOCONTRACT GmbH
01 1BOTULINUM TOXIN TYPE A
02 2INCOBOTULINUMTOXIN A
03 1botulinum toxin type a
01 2Germany
02 2U.S.A
NDC Package Code : 0023-5027
Start Marketing Date : 2024-10-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100[USP'U]/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 0023-5028
Start Marketing Date : 2024-11-04
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (200[USP'U]/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71956-202
Start Marketing Date : 2024-10-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100U/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71956-201
Start Marketing Date : 2024-11-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (50U/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 2 companies offering AbobotulinumtoxinA
Get in contact with the supplier of your choice:
